Home > Insider Trading > Filing (0001179110-13-003542)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1537668	G Christopher White	100 Hayden Avenue Lexington MA 02421	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-24	833	$0.00	833	No	4	M	Direct
Common Stock	Disposition	2013-02-25	433	$16.39	400	No	4	S	Direct
Common Stock	Disposition	2013-02-26	400	$16.37	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2013-02-24	833	$0.00	833	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
834			No	4	M	Direct

Footnotes

The shares were acquired by the reporting person as a result of the partial vesting of the restricted stock unit grant described below.
Not applicable.
The sales reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person.
Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
Grant of restricted stock unit pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in four equal installments on February 24, 2011, February 24, 2012, February 24, 2013 and February 24, 2014.